Nonpharmacological and pharmacological interventions for symptoms in Alzheimer’s disease

References

• Finkel SI, Costa E, Silva J, Cohen G, Miller S, Sartorius N. Behavioural and psychological signs and symptoms in dementia: a consensus statement on current knowledge and implications for research and treatment. Int. Psychogeriatr. 8\(Suppl. 3), 497–500 (1996).
   Google Scholar
• Margallo-Lana M, Swann A, O'Brien J et al Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. int. J: Cetiatr Psychiatry 16(1), 39–44 (2001).
   PubMed Web of Science ®Google Scholar
• Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gombein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44(12), 2308–2314 (1994).
   PubMed Web of Science ®Google Scholar
• Steinberg M, Sheppard J-M, Tschanz JT et al. The incidence of mental and behavioral disturbances in dementia: The Cache County study. Neuropsychiatry Clin. Neurosci. 15 (3), 340–345 (2003).
   Google Scholar
• Bums A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease: disorders of thought content. Br J: Psychiatry 157,92–94 (1990).
   Google Scholar
• Tariot PN. Treatment of agitation in dementia. J: Clin. PTchiatry60\(Suppl. 8), 11–20 (1999).
   Google Scholar
• Cohen-Mansfield J, Werner P, Freedman L. Sleep and agitation in agitated nursing home residents: an observational study. Sleep 18(8), 674–680 (1995).
   PubMed Web of Science ®Google Scholar
• Aalten P, de Vugt ME, Lousberg R et al Behavioural problems in dementia: a factor analysis of the Neuropsychiatry Inventory. Dement. Ceriatr Cogn. Disord. 15(2), 99–105 (2003).
   Google Scholar
• Cohen-Mansfield J. Nonpharmacologic interventions for psychotic symptoms in dementia. J: Cetiatr Psychiatry Neural 16, 219–224 (2003).
   PubMedGoogle Scholar
• Mintzer J, Targum SD. Psychosis in elderly patients: classification and pharmacotherapy. j Ceriatr Bychiatry Neural 16,199–206 (2003).
   PubMedGoogle Scholar
• Hart DJ, Craig D, Compton SA et al. A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's disease. int. J: Ceriatr PTchiatry18(11), 1037–1042 (2003).
   PubMed Web of Science ®Google Scholar
• Coen PS, Swanwick GR, O'Boyle CA, Coakley D. Behaviour disturbance and other predictors or carer burden in Alzheimer's disease. int. J: Ceriatr PTchaitry12(3), 331–336 (1997).
   Google Scholar
• O'Donnell BF, Drachman DA, Barnes HJ, Peterson KE, Swearer JM, Lew RA. Incontinence and troublesome behaviors predict institutionalization in dementia. J: Ceriatr PTchiatry Neural 5(1), 45–52 (1992).
   PubMedGoogle Scholar
• Paulsen JS, Salmon DP, Thai LJ et al Incidence of and risk factors for hallucinations and delusions in patients with probable Alzheimer's disease. Neumlogy54(10), 1965–1971 (2000).
   PubMed Web of Science ®Google Scholar
• Wimo A, Ljunggren G, Winbland B. Costs of dementia and dementia care: a review. Int. Ceriatr. Psychiatry 12(8), 841–846 (1997).
   Google Scholar
• Bosanquet N, May J, Johnson N. Alzheimer's disease in the UK: burden of disease and further care. Health Policy Review Paper 12. Imperial School of Medicine, London, UK (1998).
   Google Scholar
• McShane R, Keene J, Gedling K, Fairbum C, Jacoby R, Hope T Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow-up. Br Med. 1. 314,266–270 (1997).
   Google Scholar
• Cohen-Mansfield J, Billig N. Agitated behaviours in the elderly. J. A117. Soc. 34(10), 711–721 (1986).
   Google Scholar
• Patel V, Hope T Aggressive behaviour in elderly people with dementia: a review. int. Ceriatr Psychiatry8(3), 457–472 (1993).
   Google Scholar
• Mungas D, Weiler P, Franzi C, Henry R. Assessment of disruptive behaviour associated with dementia: the disruptive behaviour rating scale. J: Ceriatr Psychiatry Neural 2(4), 196–202 (1989).
   PubMedGoogle Scholar
• Potts HW, Richie ME, Kaas MJ. Resistance tocare.j Cerontal NUTS. 22(11), 11–16 (1996).
   Google Scholar
• Gormley N, Lyons D, Howard R. Behavioural management of aggression in dementia: a randomised controlled trial. Age Ageing30(2), 141–145 (2001).
   PubMedGoogle Scholar
• Lai CKY, Arthur DG. Wandering behaviour in people with dementia. J: Adv. Nuts. 44(2), 173–182 (2003).
   Google Scholar
• Teri L, Logsdon RG, Peskind E et al Treatment of agitation in AD. A randomized, placebo-controlled clinical trial. Neurology55,1271–1278 (2000).
   Google Scholar
• •One of the few studies that compares a nonpharrnacological with pharmacological interventions and placebo. Methodological difficulties may led to positive findings not being shown.
   Google Scholar
• Alessi CA, Yoon Ej, Schnelle JF, Nahla R, Al- Samarrai MS, Cruise PA. A randomised trial of a combined physical activity and environmental intervention in nursing home residents: do sleep and agitation improve?' Am Ceriatr. Soc. 47(7), 784–791 (1999).
   Google Scholar
• Rovner B, Steele CD, Shmuely Y, Folstein ME A randomised trial of dementia care in nursing homes. Am. Ceriatr Soc. 44(1), 7–13 (1996).
   PubMed Web of Science ®Google Scholar
• Kim EJ, Buschmann MT The effect of expressive physical touch on patients with dementia. Int. j Nurs. Stud. 36(3), 235–243 (1999).
   Google Scholar
• Synder M, Egan EC, Burns KR. Efficacy at hand massage in decreasing agitation behaviours associated with care activities in person with dementia. Geriatr Nuts. 16(2), 60–63 (1995).
   PubMedGoogle Scholar
• Neal M, Briggs M. Validation therapy for dementia (Cochrane Review). In: Cochrane Library Issue 1. John Wiley and Sons Ltd, Chichester, UK (2004).
   Google Scholar
• Spector A, Orrell M, Davies S et al Reminiscence therapy for dementia (Cochrane Review). In: Cochrane Library Issue 3. Update software, Oxford, UK (2002).
   Google Scholar
• Spector A, Orrell M, Davies S, Woods RT. Reality orientation for dementia (Cochrane Review). In: Cochrane Library Issue 2 Update software, Oxford, UK (2002).
   Google Scholar
• Koger SM, Chapin K, Brotons M. Is music therapy an effective intervention for dementia: a meta-analytic review of literature. .1. Music Ther. 36(1), 2–15 (1999).
   Google Scholar
• Gerdner LA. Effects of individualised versus classical relaxation music on the frequency of agitation in elderly persons with Alzheimer's disease and related disorders. Int. PTchogeriatr 12(1), 49–65 (2000).
   PubMed Web of Science ®Google Scholar
• Cohen-Mansfield J, Werner P. Management of verbally disruptive behaviours in nursing home residents. Gerontol 52(6), M369—M377 (1997).
   Google Scholar
• Ballard CG, O'Brien JT, Reichelt K, Perry EK. Aromatherapy as safe and effective treatment for the management agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. j Gun. Psychiatry 63(7), 553–558 (2002).
   Google Scholar
• •Good example of a well conducted randomized clinical trial (RTC) studying a nonpharrnacological intervention.
   Google Scholar
• Smallwood J, Brown R, Coulter F, Irvine E, Copland C. Aromatherapy and behaviour disturbances in dementia: a randomised controlled trial. Int. j Geriatr Psychaitry 16(10), 1010–1013 (2001).
   Google Scholar
• Holmes C, Hopkins V, Hensford C, MacLaughlin V, Wilkinson D, Rosenvinge H. Lavender oil as a treatment for agitated behaviour in severe dementia: placebo-controlled study. Int. j Geriatr Psychiatry 17(4), 305–308 (2002).
   PubMedGoogle Scholar
• Haffmans PMJ, Sival RC, Lucius SA, Cats Q, van Gelder L. Bright light therapy and melatonin in motor restlessness behaviour in dementia: a placebo-controlled study. Int.j Geriatr PTchiatry16(1), 106–110 (2001).
   Google Scholar
• Satlin A, Volicer L, Ross V, Herz L, Campbell S. Bright light treatment of behavioural and sleep disturbances in patients with Alzheimer's disease. Am. PTchiatry149(8), 1028–1032 (1992).
   Google Scholar
• Lyketsos CG, Lindell Veiel L, Baker A, Steele C. A randomized, controlled trial of bright light therapy for agitated behaviours in dementia patients residing in long-term care. Int. .1. Geriatr Psychiatry 14 (7), 520–525 (1999).
   Google Scholar
• Chung JCC, Lai CKY, Chung PMB, French HP. Snoezelen for dementia (Cochrane Review). In: The Cochrane Library Issue 1. John Wiley and Sons Ltd, Chichester, UK
   Google Scholar
• Green A, Brodaty H. Caregiver interventions. In: Evidence-Based Dementia Practice. Qizilbash N, Schneider H, Chui H et al (Eds). Blackwell Publishing, Oxford, UK, 764–794 (2002).
   Google Scholar
• McCallion P, Toseland RVV, Lacey D, Banks S. Educating nursing assistants to communicate more effectively with nursing home residents with dementia. Gerontologist 39(5), 546–558 (1999).
   PubMed Web of Science ®Google Scholar
• Haupt M, Karger A, Janner M. Improvement of agitation and anxiety in demented patients after psychoeducational group intervention with their caregivers. Int.j Geriatr PTchiatry15,1125–1129 (2000).
   Google Scholar
• Proctor R, Burns A, Powell H et al Behavioural management in nursing and residential homes: a randomised controlled trial. Lancet 354 (9172), 26–29 (1999) .
   PubMedGoogle Scholar
• McGrath AM, Jackson GA. Survey of neuroleptics prescribing in residents of nursing homes in Glasgow. BE Med. 312(7031), 611–612 (1996).
   Google Scholar
• Schneider LS, Pollock VE, Lyness SA. A meta-analysis of controlled trials of neuroleptic treatment in dementia. j Am Geritr Soc. 38(5), 553–563 (1990).
   PubMed Web of Science ®Google Scholar
• •A meta-analysis which first highlighted the efficacy of antipsychotic medications in dementia.
   Google Scholar
• Kindermann SS, Dolder CR, Bailey A, Katz JR, Jeste DV. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience. Drugs Ageing19(4), 257–276 (2002). A more up to date analysis of antipsychotic use in dementia which demonstrates not only efficacy but also the improved side-effect profile of atypical antipsychotics.
   Google Scholar
• DeDeyn PP, Rabheru K, Ramussen A et al A randomised trial of risperidone, placebo, and haloperidol for behavioural symptoms of dementia. Neurology53(5), 946–955 (1999).
   PubMedGoogle Scholar
• Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia: a randomised double-blind trial. .1. Clin. Psychiatry 60 (2), 107–115 (1999).
   Google Scholar
• Street J, Clark WS, Gannon KS et al Olanzapine treatment of psychotic and behavioural symptoms in patients with Alzheimer's disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU study group. Arch. Gen. PTchiatry57(10), 968–976 (2000).
   Google Scholar
• Herrmann N, Mamdani M, Lanctat KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am. j Psychiatry 161,1113–1115 (2004).
   Google Scholar
• Tariot PN, Ismail MS. Use of quetiapine in elderly patients. j Clin. Psychiatry 63\(Suppl. 13), 21–26 (2002).
   Google Scholar
• Cummings JL. Cholinesterase inhibitors: a new class of psychotropic compounds. Am. fiychiatry157(1), 4–15 (2000).
   PubMed Web of Science ®Google Scholar
• Winbald B, Engedal K, Soininen H. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology57(3), 489–495 (2001).
   Google Scholar
• Tariot PN, Cummings J, Katz T etal. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. j Am. Geriatr Soc. 49(12), 1590–1599 (2001).
   Google Scholar
• Feldman H, Gauthier S, Hecker J, Velles B, Subbiah P, Whalen E. for the donepezil MSAD Study Investigators Group. A 24-week, randomised, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology57(4), 613–620 (2001).
   Google Scholar
• Rosler M, Anand R, Cicin-Sian A et al Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomized controlled trial. BE Med 318(7184), 633–638 (1999).
   PubMed Web of Science ®Google Scholar
• Corey-Bloom JF, Anand R, Veach J. A randomised trial evaluating and efficacy and safety of ENA 713 (rivastigmine tartarte) a new acetykholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. int. Geriatr PTchopharmacoll(2), 55–65 (1998).
   Google Scholar
• Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilenfeld S, Ding SC for the Galantamine USA-10 Study Group. A 5-month, randomised, placebo-controlled trial of galantamine Alzheimer's disease. Neurology54(12), 2269–2276 (2000).
   Google Scholar
• Tariot PN, Erb R, Podgorski CA etal. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am. J. Psychiatry 155(1), 54–61 (1998).
   Google Scholar
• Porsteinsson AP, Tariot PN, Erb R et al. Placebo-controlled study of divalproex sodium for agitation in dementia. Am J. Geriatr fiychiatry9(1), 58–66 (2001).
   PubMedGoogle Scholar
• Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. Br. Psychiatry 157,894–901 (1990).
   PubMed Web of Science ®Google Scholar
• Lawlor BA, Radcliffe J, Molchan SE, Martinez RA, Hill JL, Sunderland T A pilot placebo-controlled study of trazodone and buspirone in Alzheimer's disease. Int. J. Geriatr. Psychiatry 9 (1), 55–59 (1994).
   Google Scholar
• Finkel SI, Mintzer JE, Dysken M, Krishman KRR, Burt T, McRae T A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. int. J. Geriatr Psychiatry 19(1), 9–18 (2004).
   Google Scholar
• Chesrow EJ, KAplitz SE, Vetra H, Breme JT, Marquardt GH. Blind study of oxazepam in the management of geriatric patients with behavioral problems. Clin. Med. 13,1001–1005 (1965).
   Google Scholar
• De Lemos GP, Clement WR, Nickels E. Effect of diazepam suspension in geriatric patients hospitalised for psychiatric illnesses. jAm. Geriatr Soc. 13,355–359 (1965).
   Google Scholar
• Coccaro EF, Kramer E, Zemishlany Z et al Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients. Am.j Psychiatry147,1640–1645 (1990).
   PubMedGoogle Scholar
• Stotsky B. Multicenter study comparing thioridazine with diazepam and placebo in elderly, nonpsychotic patients with emotional and behavioral disorders. Clin. Therapeutics6, 546–559 (1984).
   PubMedGoogle Scholar
• Christensen DB, Benfield WR. Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facilities patients. jAm. Geriatr Soc. 46,620–625 (1998).
   PubMedGoogle Scholar
• Manfredi PL, Breuer B, Wallenstein S, Stegmann M, Bottomley G, Libow L. Opioid treatment for agitation in patients with advanced dementia. Int. J. Geriatr Psychiatry 18 (8), 700–705 (2003) .
   Google Scholar
• Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioural changes in Alzheimer's disease. Neumlogy 46(1), 130–135 (1996).
   PubMed Web of Science ®Google Scholar
• Landes AM, Sperry SD, Strauss ME, Geldmacher DS. Apathy in Alzheimer's disease. Am. Geriatr Soc. 49(12), 1700–1707 (2001). Apathy is a poorly recognized symptom. This is an excellent review and discussion of the subject.
   Google Scholar
• Robert PH, Clairet S, Benoit M et al. The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. int. J. Geriatr Psychiatry 17(12), 1099–1105 (2002).
   Google Scholar
• Mann RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. PTchaitry Res. 38(2), 143–162 (1991).
   PubMedGoogle Scholar
• Teri L, Logsdon RG, Uomoto J, McCurry SM. Behavioural treatment of depression in dementia patients: a control trial. Gerontol B. Psychol. Li. Soc. Sci. 52 (4), 159–166 (1997).
   Google Scholar
• Campbell JJ, Duffy JD. Treatment strategies in amotivated patients. Psychiatric Ann. 27,44–49 (1997.)
   Web of Science ®Google Scholar
• Mann RS. Apathy and related disorders of diminished motivation. In: Review of Psychiatry Volume 15 Dickstein LJ, Riba MB, Oldaham JM (Eds). American Psychiatric Press, Washington DC, USA, 205–242 (1996).
   Google Scholar
• McMahon S, Kermode S. A clinical trial of the effect of aromatherapy on motivational behaviour in a dementia care setting using a single subject design. Aust. J. Holist. NUTS. 5(2), 47–49 (1996).
   Google Scholar
• Lord TR, Garner JE. Effects of music therapy on Alzheimer patients. Percept. Mot. Skills 76(2), 451–455 (1993).
   Google Scholar
• Gauthier S, Feldman, Hecker J et al. Efficacy of donepezil on behavioural symptoms in patients with moderate to severe Alzheimer's disease. int. PTchogetiah: 14(4), 389–404 (2002).
   PubMedGoogle Scholar
• Dartigues JF, Goulley F, Bourdiex I, Pere JJ, Barberger-Gateau P. Rivastigmine in current clinical practice in patients with mild-to-moderate Alzheimer's disease. Rev Neural 158(8-9), 807–812 (2002).
   PubMedGoogle Scholar
• Cummings J, Anand R, Koumaras B, Hartman R. Rivastigmine provides behavioural benefits to Alzheimer's disease patients in the nursing home. Findings from a 26 week trial. Neurology54\(Suppl. 3), A468 (2000).
   Google Scholar
• Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilenfeld S, Damaraju CV Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. Lancet 359(9314), 1283–1290 (2002).
   PubMed Web of Science ®Google Scholar
• Mann RS, Fogel BS, Hawkins J, Duffy J, Krupp B. Apathy: a treatable syndrome. J. Neumpsychiatry Clin. Neurosci. 7 (1), 23–30 (1995).
   Google Scholar
• Weiner MF, Debus JR, Goodkin K. Pharmacological management and treatment of dementia and secondary symptoms. In: The Dementias: Diagnosis and Management. Weiner ME (Ed.). American Psychiatric Press, Washington DC, USA, 135–166 (1991).
   Google Scholar
• Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease III: disorders of mood. BE J. Bychiatry157, 81–86 (1990).
   Google Scholar
• Rubin ER, Veiel LL, Kinscharf DA, Morris JC, Storandt M. Clinically significant depressive symptoms and very mild-to-mild dementia of the Alzheimer type. int. J. Geriatr Psychiatry 16 (7), 694–701 (2001) .
   Google Scholar
• Purandare N, Burns A, Craig S, Faragher B, Scott K. Depressive symptoms in patients with Alzheimer's disease. Int. J. Geriatr Psychiatry 16(10), 960–964 (2001).
   Google Scholar
• Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biol. Bychiatry23(3), 271–284 (1988).
   PubMed Web of Science ®Google Scholar
• Lyketsos GG, Steele C, Galik E et al Physical aggression in dementia patients and its relationship to depression. Am. J. Psychaitry156(1), 66–71 (1999).
   Google Scholar
• Snowden M, Sato K, Roy—Byrne P. Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of literature. J. Am. Geriatr Soc. 51(9), 1305–1317 (2003).
   Google Scholar
• ••Good review of assessment and treatmentof behavioral disturbance of nursing home residents with dementia which includes open-label studies as well as RCTs.
   Google Scholar
• Cheston R, Jones K, Gilliard J. Group psychotherapy and people with dementia.Aging Ment. Health 7(6) 452–461 (2003).
   Google Scholar
• Goldwasser AN, Auerbach SM, Harkins SW Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. Int. J. Aging- Hum. Av. 25(3), 209–222 (1987).
   Google Scholar
• Ashida S. The effect of reminiscence music therapy sessions on changes in depressive symptoms in elderly persons with dementia. j Musc. Ther. 37(3), 170–182 (2000).
   Google Scholar
• Sumaya IC, Rienzi BM, Deegen JF II, Moss DE. Bright light treatment decreases depression in institutionalized older adults: a placebo-controlled crossover study. Gerontol A. Biol. Li. Merl Li. 56(6), M356—M360 (2001).
   Google Scholar
• Brodaty H, Green A, Koschera A. Meta- analysis of psychosocial intervention for caregivers of people with dementia. j Am. Geriatr Soc. 51(5), 657–664 (2003).
   Google Scholar
• Katona CL, Hunter BN, Bray J. A double- blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia. Int. Geriatr fiychiatry13(2), 100–108 (1998).
   Google Scholar
• Lyketsos CG, Sheppard JM, Steele CN. Randomised, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease. Am j liychiatry 157(10), 1686–1689 (2000).
   PubMed Web of Science ®Google Scholar
• Trappler B, Cohen CI. Use of SSRIs in very old depressed nursing home residents. Am. Geriatr fiychiatry6(1), 83–89 (1998).
   PubMedGoogle Scholar
• Magai C, Kennedy G, Cohen CI, Gomberg D. A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease. Am.j Geriatr P4ychiatry8(1), 66–74 (2000).
   Google Scholar
• Lyketsos CG, DelCampo L, Steinberg M et al Treating depression in Alzheimer's disease. Arch. Gen. Psychiatry 60,737–746 (2003).
   PubMed Web of Science ®Google Scholar
• van der Wuff FB, Stek ML, Hoogendijk WJG, Beekman AT The efficacy and safety of ECT in depressed older adults: a literature review. Int. j Geriatr Psychiatry 18(10), 894–904 (2003).
   PubMedGoogle Scholar
• Vitiello MV, Prinz PN. Sleep disturbances in the elderly. In: Clinical Neurology of Aging. Albert ML, Knoefel JE (Eds). Oxford University Press, NY, USA, 637–650 (1994).
   Google Scholar
• Vitellio MV, Poceta JS, Prinz PN. Sleep in Alzheimer's disease and other dementing disorders. Can.j Psychol. 45,221–239 (1992).
   Google Scholar
• Montgomery P, Dennis J. A systematic review of nonpharmacological therapies for sleep problems in later life. Sleep Metab. Rev 8(1), 47–62 (2004).
   Google Scholar
• Beullens J, Schols J. Treatment of insomnia in demented nursing home patients: a review. Tjthchr Gerontol Geriatr 33(1), 15–20 (2002).
   Google Scholar
• McCurry SM, Gibbons LE, Logsdon RG, Vitiello M, Teri L. Training caregivers to change the sleep hygiene practices of patients with dementia: the NITE-AD project. Am. Geriatr Soc. 51(10), 1455–1460 (2003).
   Google Scholar
• Allen H, Byrne EJ, Sutherland D, Tomenson B, Butter B, Burns A. Bright light therapy, diurnal rhythm and sleep on dementia. Int. fiychogeriatrics 15\(Suppl. 12), 97–98 (2003).
   Google Scholar
• Thorgrimsen L, Spector A, Wiles A, Orrell M. Aromatherapy for dementia (Cochrane Review). In: The Cochrane Library Issue 1. John Wiley & Sons Ltd, Chichester, UK (2004).
   Google Scholar
• Lindenmuth GE Effects of music on sleep in healthy elderly and subjects with senile dementia of the Alzheimer type. Am. Alzheimers Care Rel. Dis. Report 314,13–20 (1992).
   Google Scholar
• Linnoila M, Viukari M, Lamminsiva A, Auvinen J. Efficacy and side effects of lorazepam, oxazepam and temazepam as sleeping aids in psychogeriatric inpatients. Int. Phatmacopsychiatry 15 (2), 129–135 (1980).
   PubMedGoogle Scholar
• Shaw SH, Curson H, Coquelin JR A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric inpatients. Int. Med. Res. 20(2), 150–161 (1992).
   Google Scholar
• Serfaty M, Kendell-Webb S, Warner J, Blizard R, Raven P Double-blind randomised placebo-controlled trial of low dose melatonin for sleep disorders in dementia. int. j Geriat. Bychiatry17(12), 1120–1127 (2002).
   Google Scholar
• Singer C, Tractenberg RE, Kaye J et al A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 26(7), 893–901 (2003).
   PubMed Web of Science ®Google Scholar
• Kittur S, Hauser P Improvement of sleep and behavior by methylphenidate in Alzheimer's disease. Am. j Psychiatry 156(7), 1116–1167 (1999).
   PubMedGoogle Scholar
• Cooper B. Thinking preventively about dementia: a review. int. j Geriatr liychiatry 17(10), 895–906 (2002). Website
   Google Scholar
• www.mca.gov.uldaboutagency/ regframeworldcsmicsmframe.htm (Accessed August 2004)
   Google Scholar